NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

dmb2, I agree that it does not matter too much at this point. But, I am continually testing my NWBO investment thesis, and I wanted to make sure I was not overlooking any facts or evidence that you or biosectinvestor had seen that I had not seen.

I have a lot of respect for your opinion, and biosectivestor's opinion. So, I wanted to make sure I was not missing any evidence or facts that y'all were seeing.

The specific opinion that I wanted to re-visit was, which regulatory authority imposed the partial halt, and why was it done.

In my opinion, based on all the evidence I have seen, it was the FDA who imposed the partial halt, and based upon Dr. Pazdur's own words, I believe the FDA saw clear evidence that the DCVax-L trial patients who were randomized to the control group (SOC), did not live long compared to those trial patients who were randomized to the treatment group (DCVax-L). It was clear that the SOC treated patients were only living about 14 to 16 months, while the DCVax-L treated trial patients were living 28+ months, and up to 5+ years

As a result, because there was not true clinical equipoise, it was not ethical to continue randomizing the GBM trial patients to the SOC control group.